Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of International Medical Research|January 1, 1986
Haemodynamic abnormalities in hypertensive patients: a review of the influence of vasodilating drugsU Abshagen, E von MöllendorffMethods and Findings in Experimental and Clinical Pharmacology|September 1, 1985
Digital pulse plethysmography--a tool for investigating vasoactive substancesE von Möllendorff, G NeugebauerEuropean Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blockerE von Möllendorff, K Reiff, G NeugebauerArzneimittel-Forschung|January 1, 1988
Pharmacokinetics and metabolism of torasemide in manG Neugebauer, E Besenfelder, E von MöllendorffClinical Science (London, England : 1979)|December 1, 1981
BM 12.434, a novel compound with vasodilating and beta-adrenoceptor-blocking activitiesE von Möllendorff, C Huschka, E Schröter, et al.Arzneimittel-Forschung|January 1, 1988
Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liverG Brunner, K von Bergmann, W Häcker, et al.Clinical Pharmacology and Therapeutics|June 1, 1986
Clinical pharmacologic investigations with carvedilol, a new beta-blocker with direct vasodilator activityE von Möllendorff, U Abshagen, W Akpan, et al.Journal of Cardiovascular Pharmacology|January 1, 1987
Pharmacokinetics and disposition of carvedilol in humansG Neugebauer, W Akpan, E von Möllendorff, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1985
Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N)G Neugebauer, G Betzien, V Hrstka, et al.Thrombosis and Haemostasis|November 1, 1991
Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator bm 06.022 in healthy volunteersU Martin, E von Möllendorff, W Akpan, et al.Pageof 2